ArticleBMC women's health2026
A predictive model for recurrence after hysteroscopic endometrial polypectomy: a combined analysis of clinical and ultrasound parameters.
Article in BMC women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo develop and validate a predictive model using clinical characteristics and ultrasound parameters to assess the 12-month recurrence risk following hysteroscopic endometrial polypectomy, and to explore the potential association between inflammation-related variables and recurrence.
methodsThis single-center retrospective study enrolled 170 patients who underwent hysteroscopic endometrial polypectomy between March 2023 and December 2024 and completed 12 months of follow-up. Patients were divided into a recurrence group (n = 43) and a non-recurrence group (n = 127). Clinical characteristics, ultrasound parameters, and inflammation-related indicators were collected. Multivariate logistic regression was employed to identify independent risk factors for recurrence. Receiver operating characteristic curve analysis was conducted to assess the predictive performance of individual markers and the integrated model. Risk stratification was performed using the Youden index.
resultsMultivariate analysis revealed that a history of polycystic ovary syndrome, increased endometrial thickness, and a higher number of polyps were independent predictors of postoperative recurrence (all P < 0.05). The combined predictive model demonstrated good performance, with an area under the curve of 0.8216. Following risk stratification, the high-risk group exhibited a substantially higher recurrence rate than the low-risk group (46.8% vs. 7.5%).
conclusionThe predictive model, integrating clinical and ultrasound-related factors, performed well in assessing recurrence risk after hysteroscopic endometrial polypectomy. It may serve as a useful tool for postoperative risk stratification and individualized follow-up management.
Indexed as
Identifiers
42477709What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.